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a  b  s  t  r  a  c  t
Cutaneous  melanin  pigment  plays  a critical  role  in  camouﬂage,  mimicry,  social  commu-
nication,  and  protection  against  harmful  effects  of  solar  radiation.  It has  been  proven  that
tyrosinase  plays  a  pivotal  role  in  melanocytes  dendrite  formation;  however,  the  molecu-
lar  mechanism  underlying  this  process  has  not been  fully  elucidated.  The  morphological
changes  were observed  under  a phase  contrast  microscope.  These  changes  were  evident,
with globular  cell  bodies  and  increased  numbers  of tree branch-like  dendrites.  The  present
work  aimed  to study  the  morphoanatomic  effects  of  puriﬁed  tyrosinase  to determine  its
skin-darkening  potential  using  B16F10  melanocyte,  which  has  not  been  done  to  date.  Phase
contrast  and  immunoﬂuorescence  microscopic  analysis  of B16F10  melanocytes  has  been
done after  treatment  with  various  concentrations  of  puriﬁed  tyrosinase  along  with  standard
tyrosinase (Sigma)  in  order  to explore  the  mechanism  of  action  of  puriﬁed  tyrosinase
induced  skin  darkening.  The  phase  contrast  microscopic  results  showed  that  the  num-
ber  of melanocytes  with  melanin-loaded  dendrites  has  increased  signiﬁcantly  in puriﬁed
tyrosinase  treated  cells  in  a dose  dependent  manner  leading  to skin  darkening.  In addition,
immunoﬂuorescence  microscopic  analysis  revealed  puriﬁed  tyrosinase  increase  cellular
tyrosinase expression  in  doze  dependent  manner  due  to tyrosinase  absorption  in  B16F10
melanocyte.  Present  ﬁndings  proved  that  puriﬁed  tyrosinase  possesses  a skin  darkening
potential  and  could  be  used  as a safe  melanogenic  agent  for the  treatment  of  hypopigmen-
tation  disorders  or vitiligo.
© 2016  Saudi  Society  of Microscopes.  Published  by Elsevier  Ltd.  This  is  an open  access
article  under  the  CC BY-NC-ND  license. Introduction
The unique distribution of pigments throughout the
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isms. Pigmentation is highly heritable and is regulated
y genetic, environmental, and endocrine factors that
odulate the amount, type, and distribution of melanin
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[1,2]. Melanin is a unique pigmented biopolymer that is
synthesized by specialized cells known as melanocytes,
dendritic cells that comprise a relatively minor por-
tion of the cells present in the dermal-epidermal border
of the skin. In addition to its role in the determina-
tion of phenotypic appearance and protective coloration,
melanin is involved in a number of important functions,nogenic effect of puriﬁed mushroom tyrosinase on
ence Microscopic Study. J Microsc Ultrastruct (2016),
such as balance and auditory processing, absorption of
toxic drugs and chemicals, and neurologic development
during embryogenesis [3]. Melanocytes, the specialized
skin cells are mainly involved in regulating the skin
d. This is an open access article under the CC BY-NC-ND license
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color by producing the pigment melanin. The loss of
melanin in the epidermis can increase a person’s risk
in acquiring skin cancers and result in hypopigmenta-
tion [4,5]. Any defect that affects melanocytes or their
functions often results in pigmentary disorders leading
to enhanced, reduced or complete loss of skin pigmen-
tation. The most common pigment disorders are not
disorders of melanin quality, but rather of the pigment-
producing cell itself, which may  be reduced in number,
absent, or hyperactive and commonly, with regional local-
ization. Hypomelanosis can either be acquired, e.g., vitiligo,
or congenital via inheritance of mutations in pigment-
related genes, e.g., albinisms and piebaldisms. Pigment
excess (hypermelanosis) can be associated with inﬂamma-
tory responses, as in keloid scars, or with local abnormal
melanocytes functions, as in dysplastic nevi or malig-
nant melanoma. Melanogenesis takes place in special
organelles, melanosomes, present in the melanocytes. The
biosynthetic pathway of melanogenesis has been elu-
cidated, where two types of melanins are synthesized
within melanosomes: eumelanin and pheomelanin. The
ﬁrst step of melanogenesis is initiated with tyrosine oxi-
dation to dopaquinone catalyzed by the key enzyme,
tyrosinase. Regulation of melanogenesis in mammals is
controlled at different levels and is complex at each
level [2,6].
In the present scenario various therapies are in use to
cure hypopigmentry disorders by use of synthetic agents
but they are still unsatisﬁed for treatment of skin hypopig-
mentation disease conditions, and there is a great demand
to develop more safe and effective melanogenic agents.
Recently, many efforts have been made to develop new
therapeutic agents against hypopigmentation abnormali-
ties, especially using novel biologically active compounds
from natural mushroom ﬂora. New melanogenic agents
that cause or initiate melanogenesis can be developed from
indigenous species of mushrooms. Natural plant extracts
have powerful phytochemical properties which are now
being exploited world over and there is a sudden surge
in ayurvedic or traditional uses of plant wealth in treat-
ment of diseases like cancers, arthritis, sterility, psoriasis
and diabetes. For the treatment of hypopigmentation or
vitiligo, plant extracts of Psoralea corylifolia and Ammi majus
have been used since time immemorial. Recently, it has
been reported that Psoralea corylifolia and its active ingre-
dient psoralen causes melanin granule dispersion leading
to skin darkening of Channa punctatus and Bufo melanos-
tictus. Several reports have concluded that the melanin
granule dispersion caused by Psoralea corylifolia and its
active ingredient psoralen involve muscarinic cholinergic
receptors [2,7–9].
Medicinally, mushrooms have an established history
of use in traditional oriental medicine. Many tradition-
ally used mushrooms from genera Auricularia, Flammulina,
Ganoderma, Grifola,  Lentinus, Trametes (Coriolus) and
Tremella have been demonstrated to possess signiﬁ-
cant medicinal properties [10]. Pleurotus ostreatus havePlease cite this article in press as: Zaidi KU, et al. Mela
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been used traditionally as well as medicinally in various
ailments such as anti-tumor, immunomodulatory, hypoc-
holesterolaemic, anti inﬂammatory, anti microbial and
antiviral activities [11]. Reviewing the literature it becomes PRESS
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evident that there are no conclusive data available with
regard to the effects of various mushroom tyrosinases on
melanogenesis in different vertebrate species including
human beings. Despite this, to the best of our knowledge,
there are no studies indicating extracts of mushroom as
melanogenic agents, except for the work of Zehtab et al.
[12], who  reported that mushroom tyrosinase prevented
experimental autoimmune vitiligo. Suppression of clinical
and histological disease was  observed when the animals
received mushroom tyrosinase but exact mechanism is
still unknown, so in the present work, it is not clearly
known that whether mushroom extracts induce increase
arborization of melanocytes, dendrites or increase the
number of melanin granules, or work through tyrosinase
or any other signal transduction pathway in reactiva-
ting melanin polymerization within the pigment cells or
B16F10 melanocytes.
2. Material and Methods
For the present study, the compound mushroom
tyrosinase (lyophilized powder ≥1000 unit/mg solid),
was  purchased from Sigma-aldrich St. Louis, Missouri,
United States. Goat anti-murine tyrosinase IgG anti-
body and IgG Alexa Flour ® 594 donkey anti-goat IgG
(H + L) (2 mg/mL) was  purchased from life technologies
North America, United States. Dulbecco’s Modiﬁed Eagle
Medium (AT006A-5L) Fetal bovine serum (RM10432-
100ML),Anitibiotic Antimycotic Solution 100X (A002-
20ML),Trypsin-EDTA solution1X (TCL042-5 × 100ML), MTT
{[3-(4, 5 Dimethylthiazol -2-y l)]-2, 5- diphenylte-
trazolium bromide}(TC191-500MG), 4’, 6-diamidino-2-
phenylindole (DAPI) (TC229-5MG),Phosphate buffered
saline (RM7385-1PK) and Trypan blue, Certiﬁed (RM263-
5G) were purchased from HiMedia Laboratories Pvt.Ltd.
Mumbai.
2.1. Preparation of mushroom tyrosinase
Tyrosinase from P. ostreatus was  puriﬁed by ammonium
sulphate precipitation, dialysis followed by gel ﬁltration
chromatography on Sephadex G-100, and DEAE-Cellulose
ion exchange chromatography [13].
2.2. Preparation of melanocyte culture
Melanocyte cell line B16F10 used in the study was
procured from the National Center for Cell Science, Pune
and were cultured in Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM) containing 10% heat inactivated fetal bovine
serum (FBS), 1.5 g/L NaHCO3, 2 mM L-glutamine, 10,000
units penicillin, 10 g/mL streptomycin, and 25 g/mL
amphotericin B and incubated at 37◦ C with 5% CO2 in a
humidiﬁed atmosphere. To inhibit the bacterial contamina-
tion 2% Benzalkonium chloride was kept in incubator. The
cells were subcultured in a ratio of 1:3 on every third day.nogenic effect of puriﬁed mushroom tyrosinase on
ence Microscopic Study. J Microsc Ultrastruct (2016),
For cell expansion and experiments with isolated cells, the
B16F10 cells were detached with 1X Trypsin-EDTA (0.25%
Trypsin and 0.1% EDTA in Hank’s Balanced Salt Solution).
Generally, after 3-4 passages, the cells were discarded and
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4ig. 1. Effect of puriﬁed tyrosinase of P. ostreatus (1-64 g/mL) on cell via
ean  ± SEM from triplicate experiments. p < 0.005 indicated that data wa
hen necessary the cells preserved in liquid nitrogen were
sed as fresh culture.
.3. Cell viability assay of B16F10 melanocytes
MTT  {[3-(4, 5 Dimethylthiazol -2-y l)]-2, 5- diphenyl-
etrazolium bromide} assay is colorimetric assays for
easuring the mitochondrial activity of enzymes that
educe MTT  to formazan dye, giving a purple color. When
0% conﬂuency of B16F10 melanocytes were attained,
rypsinization and seeding was done in 96 well microtitre
lates at a density of 104 cells/well in DMEM media supple-
ented with 10% FBS and 10,000 units penicillin, 10 g/mL
treptomycin, and 25 g/mL amphotericin B antibiotic
olutions. After overnight incubation, media of each well
as replaced and the cells were treated with desired stim-
lants to perform MTT  assay Kim et al. [14], to examine
ny cytotoxic effect of extracted tyrosinase of P. ostreatus
long with standard control tyrosinase (Sigma) in B16F10
ells over the concentration range of 1, 2, 4, 8, 16, 32, and
4 g/mL at different incubation periods of 24, 48 and 72
r respectively. At the completion of incubation stimulant-
ontaining media were discarded and fresh DMEM media
ontaining 1 mg/mL  of MTT  was added to each well and
ncubated at 37
◦
C for 4 h. The solution was replaced with
.04 N HCl–isopropyl alcohol solution and further incu-
ated at room temperature for 30 min. Harvested solution
as centrifuged at 13,000 rpm for 5 min  and absorbance
f supernatant was measured at 570 nm using microplate
LISA reader (Thermo Multiskan Ascent SN#354.00429).
.4. Phase contrast Microscopy
For morphologic observation under phase contrast
icroscope, the cell suspension of 1 × 105 B16F10 cells
as prepared in DMEM supplemented with 10% FBS and
10 mL)  antibiotics (10 g/mL penicillin, 10,000 unit strep-
omycin and 25 g/mL amphotericin B). On day 0, B16F10
ells in complete DMEM were dispensed into the 24 wellPlease cite this article in press as: Zaidi KU, et al. Mela
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late (105 cells per well). After an overnight incubation at
7◦C in 5% CO2 and humidiﬁed atmosphere, puriﬁed tyrosi-
ase of Pleurotus ostreatus to the ﬁnal concentration of 1, 2,
, 8, 16, 32, and 64 g/mL were added in the coated wells. B16F10 melanocytes at 24, 48 and 72 h. The results are presented as the
cant.
The plates were incubated at 37◦C for 24, 48 and 72 hrs
respectively. The cells were observed under microscope.
2.5. Immunoﬂuorescence Microscopy
In immunoﬂuorescence microscopy, immunoﬂuores-
cence staining of B16F10 cells was  carried out to determine
the tyrosinase expression Cheung et al. [15]. Immunoﬂuo-
rescence is a technique used for light microscopy with a
ﬂuorescence microscope. This technique uses the speci-
ﬁcity of antibodies to their antigen to target ﬂuorescent
dyes to speciﬁc biomolecule targets within a cell, and there-
fore allows visualisation of the distribution of the target
molecule through the sample and may  be used to ana-
lyse the distribution of proteins and small biological and
non-biological molecules. The cells were grown on glass
cover slips placed in each well of a 12 well plate (2 × 104
cells/well) for 24 h. After an overnight incubation, the puri-
ﬁed tyrosinase of Pleurotus ostreatus and standard control
mushroom tyrosinase (Sigma) were added in triplicate at
different concentration 1, 2, 4, 8, 16, 32, and 64 g/mL
for 48 h. After the incubation the cells were rinsed brieﬂy
in 1X PBS, ﬁxed at room temperature for 20 min  with 3%
paraformaldehyde and permeabilized with 0.1% Triton X-
100 in PBS followed by blocking with 10% BSA in PBS for
30 min  at room temperature. Cells were then incubated
for 15 min  with 100 L of goat anti-murine tyrosinase IgG
antibody. After washing thrice with PBS keeping the cells
for 10 min  at each wash the cells were incubated for 1 h at
room temperature with secondary antibody, donkey anti-
Goat IgG conjugated to AlexaFluor-594 in PBS buffer. Cells
were then washed with PBS and treated with 1 g/mL
4’, 6-diamidino-2-phenylindole (DAPI) for 10 min  at room
temperature to stain their nuclei. The cells were viewed and
photographed using inverted ﬂuorescence microscope.
3. Results
3.1. Cell viability assay of B16F10 melanocytesnogenic effect of puriﬁed mushroom tyrosinase on
ence Microscopic Study. J Microsc Ultrastruct (2016),
MTT  assay was performed on B16F10 cells to observe
the effect of treatment of puriﬁed mushroom tyrosinase
of P. ostreatus on cell viability at concentration ranges
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xhibite
b,c), larg
t microsFig. 2. Morphological appearance of B16F10 melanocytes. Melanocytes e
changes which showed less dendritic extensions with clear cytoplasm (
branched dendritic network (F). All photographs are under phase contras
of 1 to 64 g/mL. Tyrosinase of P. ostreatus on B16F10Please cite this article in press as: Zaidi KU, et al. Mela
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cells showed decrease in cell viability with increase in
concentration of puriﬁed mushroom tyrosinase at 1 to
64 g/mL showing 98% to 92% viability. Maximum via-
bility was observed at a concentration of 2 g/mL 98%d only 1-2 dendrites with clear cytoplasm (a), signiﬁcant morphological
e dendrites and formed a conﬂuent monolayer (d,e), multipolar highly
cope equal magniﬁcation of 200 X.
(0.376 ± 0.5 mg/1 × 105cells) (p > 0.005). Standard mush-nogenic effect of puriﬁed mushroom tyrosinase on
ence Microscopic Study. J Microsc Ultrastruct (2016),
room tyrosinase (Sigma) was  found to proliferate maxi-
mum  99.73% (0.381 ± 0.5 mg/1 × 105cells) (p < 0.005) with
respect to control as 100% (0.382 ± 0.5 mg/1 × 105cells).
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rom 48 to 72 h; along with an increase of the dose above
 g/mL, there was no further enhancement in cellu-
ar proliferation and a gradual decrease in growth was
bserved above this dose which had reached to 58.11%
0.222 ± 0.5 mg/1 × 105cells) (p < 0.005) as compared to
ontrol of 100% (0.382 ± 0.5 mg/1 × 105cells) (Fig. 1).
.2. Phase contrast microscopic observation of B16F10
elanocytes
Dendrite formation and extension comprise a char-
cteristic morphology of B16F10 melanocytes in the
kin representing one of the functional activities of
elanocytes which is the ability to transfer melanosomes
nto neighbouring keratinocytes. In phase contrast micro-
copic observation, assessment of the puriﬁed tyrosinase
f P. ostreatus on the morphology and proliferation abil-
ty of B16F10 melanocyte showed that the number of
ells proliferation and dendrite formation increased which
ere treated in dose dependent manner (1 to 64 g/mL)
or a period of 24 and 48 h. While most of the untreated
ells had only two dendrites. Standard tyrosinase (Sigma)
lso increased the melanocytes centricity and prolifera-
ion at concentration of 8 g/mL. It was found that the
reated melanocytes developed dendrites which could be
isually observed. The morphological changes in B16F10
elanocytes induced by puriﬁed tyrosinase of P. ostreatus
ere evident, with markedly globular cell bodies and sig-
iﬁcantly increased numbers of tree branch-like dendrites
s compared to untreated cells, which exhibited only 1-
 dendrites with clear cytoplasm (Fig. 2a). The minimum
oncentration of 1-4 g/mL puriﬁed tyrosinase of P. ostrea-
us caused signiﬁcant morphological changes in the B16F10
elanocytes, which showed less dendritic extensions with
lear cytoplasm when they were treated, (Fig. 2b,c). At
ncreasing concentration of puriﬁed tyrosinase of P. ostrea-
us from 8 and 16 g/mL, it was observed that B16F10
elanocytes produced large dendrites and formed a con-
uent monolayer within 24 to 48 h in culture (Fig. 2d,e). At
ighest concentration of 32 and 64 g/mL puriﬁed tyrosi-
ase of P. ostreatus under the same culture conditions, it
as found that multipolar highly branched dendritic net-
ork was formed and dense pigmented granules appeared
n the cytoplasm of the B16F10 treated cells (Fig. 2f).
.3. Immunoﬂuorescence microscopic observation of
16F10 melanocytes
Enhanced enzyme formation at the protein level is
vident at the ﬁrst instance to account the increase in
yrosinase activity. Thus, immunoﬂuorescence study was
erformed to assess the effect of puriﬁed mushroom
yrosinase of P. ostreatus on tyrosinase protein absorption
n B16F10 melanocytes. In immunoﬂuorescence micro-
copic observation distinctly higher expression of the
yrosinase protein was evident in melanocytes by intense
range red ﬂuorescence, when treated with puriﬁed tyrosi-Please cite this article in press as: Zaidi KU, et al. Mela
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ase of P. ostreatus at concentration (1 to 64 g/mL)
or 48 h. Whereas, tyrosinase expression in most of the
ntreated cells was negligible as compared to treated
ells (Fig. 3a). Expression of the tyrosinase in B16F10 PRESS
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melanocytes was  observed on treating with puriﬁed tyrosi-
nase of P. ostreatus at concentration (1 to 64 g/mL) for
48 h. B16F10 melanocytes showed higher tyrosinase levels,
concentrated in the perinuclear region. The minimum con-
centration of 1-8 g/mL puriﬁed tyrosinase of P. ostreatus
increase tyrosinase expression in dose dependent manner
and changes were observed in the B16F10 melanocytes
(Fig. 3 b- d). The maximum tyrosinase expression of treated
cells was observed at concentration varying from 16 to
64 g/mL, where intense orange red ﬂuorescence was very
much equivalent within the concentrations (Fig. 3 e-g) and
tyrosinase (Sigma) exhibited maximum tyrosinase expres-
sion at 8 g/mL (Fig. 3h). B16F10 melanocytes showed
slight decrease in intensity of ﬂorescence which is directly
related to decrease in the cellular tyrosinase at 72 h of
incubation with the puriﬁed mushroom tyrosinase at con-
centration (1 g/mL to 64 g/mL).
4. Discussion
For the past few decades, mushroom tyrosinases have
been a great concern solely due to the key role in mam-
malian melanogenesis. Melanogenesis has been deﬁned as
the entire process leading to the formation of dark macro-
molecular pigments, i.e., melanin. Melanin is formed by
a combination of enzymatically catalyzed and chemical
reactions. The enzyme extracted from the champignon
mushroom Agaricus bisporus is highly homologous with
the mammalian ones, and this renders it well suited as
a model for studies on melanogenesis. In fact, almost all
studies on tyrosinase inhibition conducted so far have used
mushroom tyrosinase because the enzyme is commercially
available [16]. The present ﬁndings suggested that tyrosi-
nase of P. ostreatus on B16F10 cells showed decrease in cell
viability with increase in concentration of puriﬁed mush-
room tyrosinase at 1 to 64 g/mL showing 98% to 92%
viability. Maximum viability was  observed at a concen-
tration of 2 g/mL 98%. Standard mushroom tyrosinase
(Sigma) was  found to proliferate maximum 99.73% with
respect to control as 100%. Whereas, when the period of
treatment was extended from 48 to 72 h; along with an
increase of the dose above 8 g/mL, there was no fur-
ther enhancement in cellular proliferation and a gradual
decrease in growth was  observed above this dose which
had reached to 58.11% as compared to control of 100%.
These ﬁndings are in agreement with those of Mallick et al.
[17], who reported the similar effects of placental total
lipid fractions (PTLF) on B16F10 melanocytes viability. It
was observed that PTLF stimulated distinct proliferative
response of B16F10 cells was evidenced from higher extent
of [3H] thymidine incorporation. The mitogenic response
was just initiated at a concentration as low as 1 mg/ml
of PTLF (101 × 6%) and reached its maximum (152%) at
10 mg/ml  as compared to the control (100%). At concentra-
tions higher than 10 mg/ml, growth stimulation started to
decline and nearly 95% of the control growth was  observed
at 200 mg/ml. The decline in growth was not due to cellnogenic effect of puriﬁed mushroom tyrosinase on
ence Microscopic Study. J Microsc Ultrastruct (2016),
death since there was  no loss of cell viability. It had been
also reported by Lee et al., 2005 [4] that the serial con-
centration of glycyrrhizin 0.2, 0.5 and 1.0 mM signiﬁcantly
increased the cell’s viability in B16 melanoma cells but
Please cite this article in press as: Zaidi KU, et al. Melanogenic effect of puriﬁed mushroom tyrosinase on
B16F10 Melanocytes: A Phase Contrast and Immunoﬂuorescence Microscopic Study. J Microsc Ultrastruct (2016),
http://dx.doi.org/10.1016/j.jmau.2016.07.002
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igniﬁcantly decreased when a concentration of 1.5 mM.
he present ﬁndings are in full agreement with those of
oon et al. [18] who reported that the effects of isopan-
uratin A and 4-hydroxypanduratin-A on cell viability,
ercentages of viable melan-a cells. Melan-a cells were
reated with various concentrations (1-100m M)  of the
ompounds for 72 h had no signiﬁcant effect on the cell via-
ility as well as morphology in B16F10 melanoma cells. The
ata of the present ﬁndings showed that puriﬁed tyrosi-
ase of P. ostreatus increased cell viability signiﬁcantly
re in full corroboration with the detailed work of Jeon
t al.[19] who have studied the effect of the main ingredi-
nts of lotus ﬂower essential oils in human melanocytes.
upplement-reduced melanocytes were stimulated with
0 g/ml of lotus ﬂower oil for 5 days. The cell viabil-
ty increased signiﬁcantly at a concentration 12.5 M and
ecreased at concentration of 25 and 50 M. Simulta-
eously, the present ﬁndings are also in full agreement
ith those of Moreira et al. [20] who reported the effect
f leaves and ﬂower extracts of P. venusta on cell viability,
t was found the vehicle used with leaves extract promoted
 signiﬁcant decrease in cell viability (12.4%), the extracts
id not show any additional cytotoxic effect on cells when
ompared with the vehicle group. Besides, the cytotoxicity
oted with the vehicle was not a concern since it was not
ble to interfere with melanin production. Cytotoxic or pro-
iferative effect of xanthoxylin on B16F10 melanoma cells
as been observed, it was found xanthoxylin at the low-
st concentration signiﬁcantly increased the cell’s viability
owever; increased the concentration it was decreased
escribed by Moleephan et al. [21]. The present ﬁndings
ave also proved that puriﬁed tyrosinase of P. ostreatus
nduce melanogenesis signiﬁcantly without causing any
ytotoxic effects, these data are in full validation with
he recent work of Yamauchi et al. [22] who reported the
ynthesis of quercetin glycosides and their melanogenesis
timulatory activity in B16 melanoma cells.
Over the last few years, the molecular mechanisms
esponsible for melanocyte dendricity have attracted
ncreasing attention in the ﬁeld of melanocyte research.
n the present study, the effect of puriﬁed tyrosinase
f P ostreatus on morphoantomical changes in B16F10
elanocytes in vitro was observed. Marked morphoantom-
cal changes were evident in B16F10 melanocytes treated
ith 1 to 64 g/ml, with globular cell bodies and increased
umbers of tree branch-like dendrites as compared to
ntreated cells, which merely exhibited 1–2 dendrites.
he minimum concentration of 1-4 g/mL puriﬁed tyrosi-
ase of P. ostreatus caused the morphological change in
he B16F10 melanocytes, where it showed less dendritic
xtensions with clear cytoplasm. At increasing concen-
ration of puriﬁed tyrosinase of P. ostreatus from 8 andPlease cite this article in press as: Zaidi KU, et al. Mela
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6 g/mL, it was observed that B16F10 melanocytes pro-
uced large dendrites and formed a conﬂuent monolayer
ithin 24 to 48 h in culture. At highest concentration of
ig. 3. Immunoﬂuorescence labeling of B16F10 treated melanocytes. Tyrosinase
uriﬁed tyrosinase (1-8 g/mL) increase tyrosinase expression in dose dependent 
f  16 to 64 g/mL (e-g), tyrosinase (Sigma) exhibited maximum tyrosinase expres
qual  magniﬁcation of 200 X. PRESS
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32 and 64 g/mL puriﬁed tyrosinase of P. ostreatus under
the same culture conditions found that multipolar highly
branched dendritic network was formed and dense pig-
mented granules appeared in the cytoplasm of the B16F10
treated cells. The present ﬁndings suggested that puriﬁed
tyrosinase of P. ostreatus showed dendritic processes with
the accumulation of the pigment granules which is similar
to the ﬁndings of Lin et al. [23] who  reported during a herbal
screening programme that both Piper nigrum extract and
piperine induced morphological alterations in melan-cells,
with more and longer dendrites observed. Mallick et al.  [17]
have found that B16F10 melanoma cells grew with large
dendrites and formed a conﬂuent monolayer within two  to
three days after treatment with placental total lipid fraction
(PTLF) in culture. Multipolar, highly branched dendritic
network and also dense pigmented granules appeared in
the cytoplasm of the treated cells. Whereas, Takeyama
et al. [24], who  demonstrated that quercetin (3,5,7,3’,4’-
pentahydroxyﬂavone) stimulates dendrites of melanocytes
which extended towards the adjacent keratinocytes in
human epidermis culture model. Similar data have been
reported by Moleephan et al. [21] where they had reported
xanthoxylin triggers signiﬁcant increase in dendrites for-
mation in B16F10 melanocytes in dose dependent manner,
which is important in transporting melanosomes to kera-
tinocytes during melanogenesis.
In this series of experiments, the qualitative mea-
surement of tyrosinase expression was performed by
immunoﬂuorescence staining method. Enhanced enzyme
formation at the cellular protein level is evident at the
ﬁrst instance to account the increase in tyrosinase activ-
ity. Thus, immunoﬂuorescence study was performed to
assess the effect of puriﬁed mushroom tyrosinase of P.
ostreatus on tyrosinase protein absorption on B16F10
melanocytes. The ﬁndings of the present study distinctly
exhibit higher expression of the tyrosinase protein as evi-
dent in melanocytes by intense orange red ﬂuorescence,
when treated with puriﬁed tyrosinase of P. ostreatus at con-
centration (1 to 64 g/mL) for 48 h. Whereas, tyrosinase
expression in most of the untreated cells was negligible as
compared to treated B16F10 melanocytes which showed
higher tyrosinase levels to be more concentrated in the
perinuclear region when incubated for 48 h with puriﬁed
mushroom tyrosinase. It was  also observed that on longer
incubation period (72 h) with the puriﬁed mushroom
tyrosinase, B16F10 melanocytes showed slight decrease in
intensity of ﬂorescence at all the concentrations (1 g/mL
to 64 g/mL) employed, indicating decrease in the cellu-
lar tyrosinase. The present ﬁndings have proved distinctly
higher expression of tyrosinase within the cytoplasm in
the B16F10 melanocytes, treated with puriﬁed tyrosinase
of P. ostreatus, this can be correlated with the ﬁndingsnogenic effect of puriﬁed mushroom tyrosinase on
ence Microscopic Study. J Microsc Ultrastruct (2016),
of Mallick et al. [17], who  have reported the effect of
placental peptide on tyrosinase protein expression using
immunoﬂuorescence studies. It was  found that B16F10
 expression negligible in untreated cells (a), minimum concentration of
manner (b-d), maximum tyrosinase expression observed at concentration
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cells showed distinctly higher expression of the tyrosi-
nase protein within the cytoplasm of the cells treated
with 10 g/ml PP and 50 g/ml PPPF for 48 h compared to
basal level expression of the protein in untreated control.
Park et al. [25] have reported the effects of harmaline and
harmalol on tyrosinase expression. It was observed that
harmaline and harmalol stimulated melanin synthesis and
tyrosinase activity, as well as expression of tyrosinase, TRP-
1 and TRP-2. On the other hand, tyrosinase expression in
the B16F10 melanocytes can be increased by exposure of
the cells to agents that raise intracellular levels of cAMP,
such as dibutyryl cAMP (dbcAMP), isobutylmethyl xan-
thine (IBMX), hydroalcoholic extracts of leaves and ﬂowers
of P. venusta and Kaliziri extract (KZ) [20,26,27]. Here we
present a microscopic approach through which it becomes
clear that tyrosinase of P. ostreatus has various biological
advantages such as gentle effectiveness and without cyto-
toxicity. It is a potent mushroom tyrosinase for darkening
and photoprotection. From the data of the present work,
it is also concluded that tyrosinase is the key in regulation
of melanin production; the study conducted on the effect
of puriﬁed tyrosinase absorption and its effects has shown
that mushroom tyrosinase as an effective agent for melano-
genesis and can serve as a potent melanogenic agent to cure
vitiligo.
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